Tetrazolium-based Assays for Cellular Viability: A Critical Examination of Selected Parameters Affecting Formazan Production

Cancer Research

Volumn 51, Issue 10, 1991, Pages 2515-2520

  Vistica, David T ^a,d   Monks, Anne ^b,c   Pittman, Angela ^a   Boyd, Michael R ^a  

^a Laboratory of Drug Discovery Research and Development   (United States)

^b Program Resources ^*  (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ARTICLE; CELL VIABILITY; DRUG SCREENING; PRIORITY JOURNAL; TUMOR CELL LINE;

CARCINOMA, RENAL CELL; CELL DIVISION; CELL LINE; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; DYES; FORMAZANS; GLUCOSE; HUMAN; KIDNEY NEOPLASMS; KINETICS; LEUKEMIA, MYELOID, CHRONIC; NAD; NADP; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0025738516     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Boyd, M. R. Status of the NCI preclinical antitumor discovery screens. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.). Cancer Principles and Practice of Oncology, Vol. I., pp. 1-12. Philadelphia: J. B. Lippincott Co., 1989.
2. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., and Boyd, M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48: 589-601, 1988.
3. Scudiero, D. A., Shoemaker, R. H., Pauli, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D., and Boyd, M. R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 48:4827-4833, 1988.
4. Vistica, D. T., Scudiero, D., Skehan, P., Monks, A., and Boyd, M. R. New carbon-dioxide independent basal growth medium for culture of diverse tumor and nontumor cells of human and nonhuman origin. J. Natl. Cancer Inst., 52: 1055-1061,1990.
5. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
6. Klingenberg, M. Nicotinamide-adenine dinucleotides (NAD, NADP, NADH, NADPH). Spectrophotometric and fluorimetric methods. In: Methods of Enzymatic Analysis, Ed. 2, Vol. 4, pp. 2055-2056. New York: Academic Press, 1974.
7. Leibovitz, A. The growth and maintenance of tissue-cell cultures in free gas exchange with the atmosphere. Am. J. Hyg. 78: 173-180,1963.
8. Beyer, H., and Pyl, T. Uber thiazole. XXIV. Mitteil: über C.,N-diphenyl-N'-thiazolyl-(2)-formazane und deren tetrazoliumsalze. Chem. Ber., 87: 1505-1511,1954.
9. Altman, F. P. Tetrazolium salts: A consumer's guide. Histochem. J., 8:471-485, 1976.
10. Slater, T. F., Sawyer, B., and Strauli, U. Studies on succinate-tetrazolium reductase systems III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta, 77:383-393, 1963.
11. Pearse, A. G. E. Histochemistry, Theoretical and Applied, Ed. 3, Vol. 2. Edinburgh: Churchill Livingstone, 1972.
12. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
13. Boyd, M. R. National Cancer Institute new drug development program. In: E. J. Frei and E. J. Freireich (eds.). Accomplishments in Oncology, Vol. 1, pp. 68-76. Philadelphia: J. B. Lippincott Co., 1986.
14. Plumb, J. A., Milroy, R., and Kaye, S. B. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res., 49:4435-4440, 1989.
15. Jabbar, S. A. B., Twentyman, P. R., and Watson, J. V. The MTT assay underestimates the growth inhibitory effects of interferons. Br. J. Cancer, 60: 523-528, 1989.
16. Rubinstein, L. V., Shoemaker, R. H., Pauli, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A., and Boyd, M. R. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl. Cancer Inst., 82:1113-1118,1990.
17. Skehan, P., Storeng, R., Scudiero, D. A., Monks, A., McMahon, J. B., Vistica, D. T., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl. Cancer Inst., 52: 1107-1112, 1990.
18. Knauf, P. A., and Rothstein, A. Chemical modification of membranes L Effects of sulfhydryl and amino reactive reagents on anion and cation permeability of the human red blood cell. J. Gen. Physiol., 58: 190-210, 1971.
19. Knauf, P. A., and Rothstein, A. Chemical modification of membranes II. Permeation paths for sulfhydryl agents. J. Gen. Physiol., 58:211-223,1971.
20. Vistica, D. T., Skehan, P., Scudiero, D. A., Monks, A., and Boyd, M. R. Tetrazolium-based assays for cellular viability: A critical examination of parameters which affect formazan production. Proc. Am. Assoc. Cancer Res., 30:612, 1989.